Clinical Research Directory
Browse clinical research sites, groups, and studies.
Community-Based Screening for Chronic Kidney Disease
Sponsor: University of Texas at Austin
Summary
Chronic Kidney Disease (CKD) incubates for years before kidney function declines to such low levels that patients develop symptoms and present for medical evaluation. The earlier in its course that CKD is identified, the more likely that medical care can slow or stop further worsening toward complete loss of kidney function, or end-stage kidney disease (ESKD). Individuals living in low income, largely minority communities are at greater risk for CKD than those in wealthier, non-minority communities but have historic mistrust of research. This project will conduct screening for high levels of a urine protein called albumin, indicating underlying CKD, in churches known to have the trust of communities, to identify asymptomatic individuals with CKD to be offered referral for kidney-protective medical care. Upon completion, this project will determine if individuals so identified with CKD will 1) accept referral for CKD care; 2) remain in care for at least 12 months; and 3) achieve a reduction in urine albumin levels, indicating CKD improvement. As such, this project will determine the value of community-based screening to reduce CKD prevalence.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
145
Start Date
2006-06-21
Completion Date
2024-05-10
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
outpatient clinic kidney-protective care
Participants in the Placebo Comparative group are those who decline outpatient referral for outpatient clinic kidney-protective medical care and so receive no medical care
Locations (1)
Dell Medical School - The University of Texas at Austin
Austin, Texas, United States